GENETICS OF THE CHOROID AND IMPACT ON EYE HEALTH
Dr Samantha Lee,
Senior Research Fellow
Lions Eye Institute &
The University of Western Australia,
Perth, Western Australia
RESEARCHER PROFILE
Filmed in Perth, Australia | September 2025
Dr Samantha Lee is a Senior Research Fellow at Lions Eye Institute and the University of Western Australia. Dr Lee obtained her PhD in 2017 and the Queensland University of Technology and has since been working on the genetics and environmental causes of various eye diseases, with a focus on glaucoma and myopia. She has published 57 full-length scientific papers and her work has been cited over 1,000 times. She serves on the Editorial Board for the journal BMC Ophthalmology and Scientific Reports, and on the Research Advisory Committee for the Ophthalmic Research Institute of Australia.
Dr Lee’s research is being supported by the Western Australia Future Health Research and Innovation Fund (2024–27), Medical Research Future Fund (2025–27), Perth Eye Foundation (2024), and the Lions Eye Institute Strategic Funding (2024).
Source: Supplied
-
Next Generation Condom Contraception, Dr Simon Cook
Dr. Simon Cook, Co-Founder and Executive Director of Operations at Eudaemon Technologies, has had a diverse and impactful career journey. Beginning with a background in biotechnology from the University of Wollongong, his focus on bacterial pathogenesis during his PhD led him to study Group A Strep and the streptokinase protein.
Subsequently, Dr. Cook ventured into a unique project funded by the Bill and Melinda Gates Foundation, where he became involved in the development of a next-generation condom to address existing issues such as feel, odour, and taste.
-
Oral administration of insulin for Type 1 Diabetes
Huiwen Pang is a 3rd year PhD candidate in the Australian Institute for Bioengineering and Nanotechnology, University of Queensland, focusing on biomedical health research. Prior to commencing his PhD, Huiwen studied animal genetics in his Masters degree at Huazhong Agriculture University in China.
People with diabetes, especially Type 1 diabetes, largely rely on the insulin injections or insulin pumps to control their high blood glucose levels, which is painful and has a high risk of infections.
Huiwen Pang is conducting research on nano-based drug formulations for Type 1 diabetes treatment, with a focus on using nanomaterials to load insulin for oral administration and employing anti-apoptotic and anti-inflammatory approaches to mitigate damage to beta cells.
-
Nutraceutical and pharmacological intervention in neurological disorders
Dr Virginie Lam is a neuroscientist and cerebrovascular biologist with over 15 years of research experience, including more than seven years post-PhD. She co-leads the Neurovascular and Metabolic Diseases Laboratory at the Curtin Medical Research Institute and holds an affiliate appointment at the Perron Institute for Neurological and Translational Science. Her research focuses on the interface between neurovascular health, cognitive function, and therapeutic translation in neurodegenerative disorders.
